TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2025
Back to search
Official data from USPTO
SYNEURX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
05/14/2025
Trademark type
Word
Nice classes
5, 42
Filing date
07/01/2016
Registration date
03/06/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/02/2024
Last transaction
05/14/2025
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2014-06-00
First use in commerce
2014-06-00
Drawing code
4
Owner type
03
Owner location
Taipei City 110, TW
Examiner
DELGIZZI, RONALD
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SyneuRx International Corp.
Representatives
Paul Cosmovici
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products and substances for treating neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; medicines for neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; pharmaceutical preparations for neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; sodium salts for medical purposes
Class 42
Pharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; Biological research; Clinical lab test of medical reagents for conducting clinical trials for others in the field of neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; Scientific research and analysis in the field of medical reagents; Providing research and development of technology in the field of neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; Technical research in the field of neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; Technical project studies in the field of neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; Scientific laboratory services
Publications
History of USPTO decisions and trademark events.
32 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/07/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
10/02/2024
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
10/02/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/25/2024
ES8R
TEAS SECTION 8 RECEIVED
02/21/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/06/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/25/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/25/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/25/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/06/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/31/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/30/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/30/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/30/2018
IUAF
USE AMENDMENT FILED
01/18/2018
EISU
TEAS STATEMENT OF USE RECEIVED
01/18/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/18/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/23/2017
PUBO
PUBLISHED FOR OPPOSITION
05/23/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/03/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/14/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/01/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/13/2016
GNRT
NON-FINAL ACTION E-MAILED
10/13/2016
CNRT
NON-FINAL ACTION WRITTEN
10/13/2016
DOCK
ASSIGNED TO EXAMINER
10/12/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/06/2016
NWAP
NEW APPLICATION ENTERED
07/05/2016
Continuous trademark protection
Get notified about every new filing that threatens SYNEURX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.